News

Find News

Filter articles

Showing 2441 to 2450 of 2541 results

PolyTherics completes Antitope takeover

UK12-09-2013

UK biopharmaceuticals company PolyTherics has completed a takeover of Antitope, a provider of antibody engineering and immunogenicity screening services.

AIPPI 2013: Pharmaceutical products and the trademark hiccup

EU07-09-2013

The annual International Association for the Protection of Intellectual Property conference in Helsinki has been assessing the potential problems for pharmaceutical companies trying to brand their medicinal products.

BioEconomy Academy launches in Bangkok

Thailand04-09-2013

Law firm Rouse has teamed up with two organisations to open the BioEconomy Academy, an initiative aimed at boosting IP use and awareness in Thailand.

Amici submit brief to support Ambry in Myriad case

US30-08-2013

The American Civil Liberties Union and other groups have submitted an amici curiae brief in support of Ambry Genetics and Gene by Gene in their patent infringement cases with Myriad Genetics Inc.

Marks & Clerk UK promotes two to partnership

UK28-08-2013

UK IP firm Marks & Clerk LLP has announced two of its attorneys will be joining the firm’s partnership.

Austria becomes first country to ratify Unified Patent Court agreement

Austria, EU27-08-2013

Austria has become the first country in the EU to ratify consent to the Unified Patent Court.

Miles & Stockbridge welcomes eight IP professionals

US23-08-2013

US law firm Miles & Stockbridge PC has continued the expansion of its IP practice with the addition of seven lawyers and one patent agent.

Eli Lilly bids to stop generics cutting Alimta exclusivity

US23-08-2013

Eli Lilly has begun its defence of a patent covering lung cancer drug Alimta against generic companies including Teva, Barr Laboratories and APP Pharmaceuticals.

Horizon Pharma settles Duexis case with Par Pharmaceuticals

US22-08-2013Legal developments

US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies.

Roche relinquishes patent on breast cancer drug

India19-08-2013

Drugmaker Roche has decided not to pursue a patent application for a breast cancer drug in the Indian market, enabling rivals to possibly produce cheaper versions.

Showing 2441 to 2450 of 2541 results

LSIPR